• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过广义相加模型(GSP)根据胎龄和采血时年龄调整先天性肾上腺皮质增生症新生儿筛查的17-羟孕酮临界值。

The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.

作者信息

Jiang Xiang, Tang Fang, Feng Yi, Li Bei, Jia Xuefang, Tang Chengfang, Liu Sichi, Huang Yonglan

机构信息

Guangzhou Newborn Screening Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, P.R. China.

Guangzhou Newborn Screening Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510180, Guangdong Province,P.R. China, Phone/Fax: +86-20-81330406.

出版信息

J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1253-1258. doi: 10.1515/jpem-2019-0140.

DOI:10.1515/jpem-2019-0140
PMID:31603856
Abstract

Background Congenital adrenal hyperplasia (CAH) screening is facing great challenges because of a high false-positive rate and a low positive predictive value (PPV). We established and optimized 17-hydroxyprogesterone (17-OHP) cut-off values for CAH neonatal screening using a genetic screening processor (GSP) according to gestational age (GA), birth weight (BW) and age at sampling. Methods The 17-OHP concentrations in dried blood spots were measured by time-resolved immunofluorescence and were grouped in terms of GA, BW and age at sampling for 48,592 newborns. The 99.5th percentile was used to set an initial cut-off value as a reference. Results Significant differences in 17-OHP concentrations were observed among newborns with different GAs and BWs. A significant difference was observed among different sampling age groups. Finally, we defined new multitier cut-off concentrations based on GA and age at sampling. Application of the new cut-off values resulted in a 30% reduction of the positive rate and a 40% increase of the PPV. Conclusions GA, BW and sampling age time influenced the concentrations of 17-OHP. The efficiency of congenital adrenal hyperplasia screening can be substantially improved by adjusting the multitier cut-off value according to GA and age at sampling.

摘要

背景 由于先天性肾上腺皮质增生症(CAH)筛查的假阳性率高且阳性预测值(PPV)低,该筛查面临巨大挑战。我们使用基因筛查处理器(GSP),根据胎龄(GA)、出生体重(BW)和采样时的年龄,建立并优化了用于CAH新生儿筛查的17-羟孕酮(17-OHP)临界值。方法 采用时间分辨免疫荧光法测定48592例新生儿干血斑中的17-OHP浓度,并根据GA、BW和采样时的年龄进行分组。以第99.5百分位数作为初始临界值的参考。结果 不同GA和BW的新生儿17-OHP浓度存在显著差异。不同采样年龄组之间也观察到显著差异。最后,我们根据GA和采样时的年龄定义了新的多层临界浓度。应用新的临界值使阳性率降低了30%,PPV提高了40%。结论 GA、BW和采样年龄影响17-OHP的浓度。根据GA和采样时的年龄调整多层临界值可显著提高先天性肾上腺皮质增生症筛查的效率。

相似文献

1
The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.通过广义相加模型(GSP)根据胎龄和采血时年龄调整先天性肾上腺皮质增生症新生儿筛查的17-羟孕酮临界值。
J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1253-1258. doi: 10.1515/jpem-2019-0140.
2
Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.巴西南部先天性肾上腺皮质增生症的新生儿筛查:一项针对108409名婴儿的基于人群的研究。
BMC Pediatr. 2017 Jan 17;17(1):22. doi: 10.1186/s12887-016-0772-x.
3
Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.先天性肾上腺皮质增生症的筛查:将17-羟孕酮临界值同时根据年龄和出生体重进行调整可显著提高预测价值。
J Clin Endocrinol Metab. 2003 Dec;88(12):5790-4. doi: 10.1210/jc.2002-021732.
4
Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.根据样本采集时的年龄和出生体重调整的新生儿17-羟孕酮水平可提高先天性肾上腺皮质增生症新生儿筛查的效果。
Clin Endocrinol (Oxf). 2017 Apr;86(4):480-487. doi: 10.1111/cen.13292. Epub 2017 Jan 23.
5
Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.意大利东北部先天性肾上腺皮质增生症的新生儿筛查:该项目开展三年的报告
Horm Res. 2005;63(4):180-6. doi: 10.1159/000085021. Epub 2005 Apr 7.
6
Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.确定早产、低出生体重和患病新生儿先天性肾上腺皮质增生症的17-羟孕酮临界值。
Exp Clin Endocrinol Diabetes. 2023 Apr;131(4):216-221. doi: 10.1055/a-2022-8399. Epub 2023 Feb 28.
7
The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.季节性和制造商试剂盒批次变化对新生儿17α-羟孕酮测量及先天性肾上腺皮质增生症转诊率的影响。
Eur J Pediatr. 2017 Jan;176(1):121-129. doi: 10.1007/s00431-016-2814-7. Epub 2016 Nov 29.
8
Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.新生儿重症监护病房入院期间17-羟孕酮水平升高的危险因素。
Acta Clin Belg. 2012 Mar-Apr;67(2):88-93. doi: 10.2143/ACB.67.2.2062637.
9
Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.先天性肾上腺皮质增生症新生儿筛查项目:召回方案的调整
Horm Res. 2001;55(6):271-7. doi: 10.1159/000050012.
10
Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.古巴先天性肾上腺皮质增生症的新生儿筛查:六年经验。
Clin Chim Acta. 2013 Jun 5;421:73-8. doi: 10.1016/j.cca.2013.02.020. Epub 2013 Feb 26.

引用本文的文献

1
Implementing and validating newborn screening for inborn errors of metabolism in South India: a 2-year observational study at a tertiary care hospital.在印度南部实施并验证先天性代谢缺陷的新生儿筛查:一家三级护理医院的两年观察性研究。
BMJ Public Health. 2024 Nov 27;2(2):e001459. doi: 10.1136/bmjph-2024-001459. eCollection 2024 Dec.
2
Interpretation of Neonatal Adrenal Function Results and Adrenal Function Results in Critical Illness.新生儿肾上腺功能结果及危重症时肾上腺功能结果的解读
J Clin Res Pediatr Endocrinol. 2025 Jan 10;17(Suppl 1):44-53. doi: 10.4274/jcrpe.galenos.2024.2024-6-1-S. Epub 2024 Dec 23.
3
Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia.
沙特阿拉伯新生儿代谢缺陷症筛查的截断值。
Ann Saudi Med. 2022 Mar-Apr;42(2):107-118. doi: 10.5144/0256-4947.2022.107. Epub 2022 Apr 7.
4
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.先天性肾上腺皮质增生症-病理生理学、诊断和治疗的最新见解。
Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016.
5
A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns.中国对与严重遗传性疾病相关的573个基因进行扩大新生儿筛查的一项试点研究:1127名新生儿的结果。
Ann Transl Med. 2020 Sep;8(17):1058. doi: 10.21037/atm-20-1147.
6
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy.先天性肾上腺皮质增生症的新生儿筛查:影响筛查准确性的因素综述
Int J Neonatal Screen. 2020 Aug 23;6(3):67. doi: 10.3390/ijns6030067. eCollection 2020 Sep.